Longboard Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing transformative medicines for neurological disorders. With a deep understanding of the genetic drivers of these conditions, Longboard is committed to advancing innovative therapies and improving the lives of patients worldwide.